ARCHIVES

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

This article is from The Cancer Letter archive.

Vol. 09 No. 42 | November 4, 1983

Download PDF Visit The Full Archive

Related Articles

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

NCI funds biorepository for prostate cancer SPOREs.

November 11, 2005

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984